Gel may shield liver cancer patients from painful side effect
NCT ID NCT07560566
First seen May 14, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tests if applying a gel containing indomethacin to the hands before starting sorafenib can prevent or reduce hand-foot syndrome, a common and painful skin reaction. It involves 39 adults with advanced liver cancer who are about to begin sorafenib treatment. Participants will use the gel twice daily for up to 12 weeks, and researchers will compare the rate of skin reactions to historical data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATO CELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, 10002, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.